TLPH

Talphera (TLPH)

About Talphera (TLPH)

Talphera, Inc. engages in the development and commercialization of therapies used in medically supervised settings. The firm's portfolio includes Nafamostat, LTX-608, and Niyad. The company was founded by Thomas A. Schreck and Pamela Pierce Palmer on July 13, 2005 and is headquartered in San Mateo, CA.

Details

Daily high

$1.44

Daily low

$1.38

Price at open

$1.40

52 Week High

$1.57

52 Week Low

$0.39

Market cap

70.1M

Dividend yield

0.00%

Volume

343,491

Avg. volume

316,080

P/E ratio

-4.49

Talphera News